AMLX Amylyx Pharmaceuticals Inc
2,229
$1.97
$0.02
(1.00%)
| Watchers | 2,229 |
| 52-Wk Low | $1.70 |
| 52-Wk High | $30.50 |
| Market Cap | $133.97M |
| Volume | 900,905.00 |
| 52-Wk High | $30.50 |
| 52-Wk Low | $1.70 |
Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024Business Wire • 6 days ago
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (Amylyx or the Company) will report its first quarter 2024 financial results on Thursday, May 9, 2024. Amylyx senior management team will host a conference...
Share to Feed
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx or the Company) today announced interim data from the ongoing Phase 2 HELIOS clinical trial of AMX0035 (sodium phenylbutyrate [PB] and taurursodiol...
The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AMLX The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class...
The Law Offices of Frank R. Cruz reminds investors of the upcoming April 9, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Amylyx...
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (Amylyx or the Company) today announced the Company will host a virtual webcast with management and Fumihiko Urano, MD, PhD, Principal Investigator of the...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc.(AMLX) Shareholders Levi & Korsinsky Announces the Filing of a Securities Class Action on...
Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AMLX Amylyx Pharmaceuticals, Inc. Sued for Securities Law...
AMLX Investors Have Opportunity to Lead Amylyx Pharmaceuticals, Inc. Securities Fraud Lawsuit AMLX Investors Have Opportunity to Lead Amylyx Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire...
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx or the Company) today announced the Company has started a process with the U.S. Food and Drug Administration (FDA) and Health Canada to voluntarily...
AMLX FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities...